Transcriptional analysis of chondrogenic and osteogenic genes. by Melissa A. MacIver (12850566)

Coenzyme Q Biosynthesis: Evidence for a Substrate Access Channel in the FAD-Dependent Monooxygenase Coq6 by Alexandre Ismail (847754)

“…We identify a putative access channel for Coq6 in a wild type model and propose <i>in silico</i> mutations positioned at its entrance capable of partially (G248R and L382E single mutations) or completely (a G248R-L382E double-mutation) blocking access to the channel for the substrate. …”

The Homeobox Gene <i>MEIS1</i> Is Methylated in <i>BRAF</i>^p.V600E Mutated Colon Tumors by Ashwin A. Dihal (481201)

“…Four out of eight <i>BRAF</i>^p.V600E tumor epithelial fractions (50%) showed <i>MEIS1</i> promoter methylation, as well as three out of eight <i>BRAF</i>^p.V600E stromal fractions (38%). …”

Fig 1 - by Amanda B. Hassinger (7498802)

Analysis of color parameters (<i>L</i>, <i>a</i>, <i>b</i>*) and color difference (Δ<i>E</i>*_<i>ab</i>) values^a before and after hypoxic stress in cherry shri... by Wei-Wei Hou (3405947)

Data_Sheet_1_Prenatal Diagnosis in a Fetus With X-Linked Recessive Chondrodysplasia Punctata: Identification and Functional Study of a Novel Missense Mutation in ARSE.docx by Li Zhang (8200)

“…In the current study, a novel missense mutation (c.265A > G) in ARSE was identified in a fetus with short limbs using whole-exome sequencing (WES). …”

Stereo Microscopy Samples (a) ABS (800 rpm,10 mm/min) (b) ABS (1200 rpm,10 mm/min) (c) ABS (1200 rpm,20 mm/min) (d) PC (800 rpm,40 mm/min) (e) PC (1200 rpm,20 mm/min).... by Shaheer Ahmed Khan (17797647)

Simulation 1 model fits. by Jordan Barnes (12256947)

Reduced Parasite Motility and Micronemal Protein Secretion by a p38 MAPK Inhibitor Leads to a Severe Impairment of Cell Invasion by the Apicomplexan Parasite <i>Eimeria tenella</i> by Françoise I. Bussière (692733)

“…<div><p><i>E</i>. <i>tenella</i> infection is associated with a severe intestinal disease leading to high economic losses in poultry industry. …”

This supplement contains a full list of differentially expressed genes, including which population the gene is differentially expressed in (more-tolerant or less-tolerant), the ann... by Amberleigh E. Henschen (3257235)

CAP256-VRC26 bnAbs maintain neutralization activity against cell-cell transmission of autologous viruses. by Lucia Reh (546554)

Comparison between fitted model (solid lines) and data (markers) at the whole lung scale (a) and in three example grids from row 11, columns 3, 5, and 8, which are at different ele... by Monica E. Shapiro (22622240)

Change from full-scale to reduced model in sum (across all time points and grids) of squared error between model and MC scan data as a function of the number of clusters used in th... by Monica E. Shapiro (22622240)

CCND1 is a target gene of miR-1247-3p. by Dequan Wang (6007007)

image2_Myostatin Promotes Osteoclastogenesis by Regulating Ccdc50 Gene Expression and RANKL-Induced NF-κB and MAPK Pathways.tif by Xin Zhi (1829224)

“…In RAW264.7 cells and bone marrow monocytes (BMMCs), myostatin activates the expression of the II type receptor ActR II B. Here, we report that myostatin significantly promoted RANKL/M-CSF-induced osteoclastogenesis and activated NF-κB and MAPK pathways in vitro via the Ccdc50 gene. …”

presentation1_Myostatin Promotes Osteoclastogenesis by Regulating Ccdc50 Gene Expression and RANKL-Induced NF-κB and MAPK Pathways.pptx by Xin Zhi (1829224)

“…In RAW264.7 cells and bone marrow monocytes (BMMCs), myostatin activates the expression of the II type receptor ActR II B. Here, we report that myostatin significantly promoted RANKL/M-CSF-induced osteoclastogenesis and activated NF-κB and MAPK pathways in vitro via the Ccdc50 gene. …”

image3_Myostatin Promotes Osteoclastogenesis by Regulating Ccdc50 Gene Expression and RANKL-Induced NF-κB and MAPK Pathways.tif by Xin Zhi (1829224)

“…In RAW264.7 cells and bone marrow monocytes (BMMCs), myostatin activates the expression of the II type receptor ActR II B. Here, we report that myostatin significantly promoted RANKL/M-CSF-induced osteoclastogenesis and activated NF-κB and MAPK pathways in vitro via the Ccdc50 gene. …”

presentation1_Myostatin Promotes Osteoclastogenesis by Regulating Ccdc50 Gene Expression and RANKL-Induced NF-κB and MAPK Pathways.pptx by Xin Zhi (1829224)

“…In RAW264.7 cells and bone marrow monocytes (BMMCs), myostatin activates the expression of the II type receptor ActR II B. Here, we report that myostatin significantly promoted RANKL/M-CSF-induced osteoclastogenesis and activated NF-κB and MAPK pathways in vitro via the Ccdc50 gene. …”

presentation1_Myostatin Promotes Osteoclastogenesis by Regulating Ccdc50 Gene Expression and RANKL-Induced NF-κB and MAPK Pathways.pptx by Xin Zhi (1829224)

“…In RAW264.7 cells and bone marrow monocytes (BMMCs), myostatin activates the expression of the II type receptor ActR II B. Here, we report that myostatin significantly promoted RANKL/M-CSF-induced osteoclastogenesis and activated NF-κB and MAPK pathways in vitro via the Ccdc50 gene. …”

image1_Myostatin Promotes Osteoclastogenesis by Regulating Ccdc50 Gene Expression and RANKL-Induced NF-κB and MAPK Pathways.tif by Xin Zhi (1829224)

“…In RAW264.7 cells and bone marrow monocytes (BMMCs), myostatin activates the expression of the II type receptor ActR II B. Here, we report that myostatin significantly promoted RANKL/M-CSF-induced osteoclastogenesis and activated NF-κB and MAPK pathways in vitro via the Ccdc50 gene. …”